Center for Translational Pediatric Research (CTPR): Enhancing SARS-CoV-2 Sequencing Efforts for Variants in the State of Arkansas
转化儿科研究中心 (CTPR):加强阿肯色州 SARS-CoV-2 变异体的测序工作
基本信息
- 批准号:10595406
- 负责人:
- 金额:$ 77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-11 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVArkansasAwardBioinformaticsBiomedical ResearchCell NucleusCenters of Research ExcellenceChildChildhoodData AnalysesDevelopment PlansDiseaseExtramural ActivitiesFoundationsFundingGenomicsGoalsGrantHuman ResourcesIndividualInstitutionLeadershipMalignant NeoplasmsMentorsMissionNational Institute of General Medical SciencesPediatric ResearchPhasePilot ProjectsPopulationProgram DevelopmentProteomicsResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch Project GrantsResearch SupportResourcesRoleStructureSupport SystemSystems BiologyTeacher Professional DevelopmentVariantcareerdata integrationdisease mechanisms studyepigenomicsexperiencefaculty mentormembermid-career facultymultidisciplinaryprofessorprogramsproteogenomicsrecruitsenior facultyservice providerssuccesstenure tracktherapeutic target
项目摘要
Summary
In July of 2017, we launched Phase I of the COBRE Center for Translational Pediatric Research at Arkansas
Children’s Research Institute in Little Rock, Arkansas. The mission of the center is to use proteogenomic
approaches to identify epigenomic mechanisms and therapeutic targets in diseases, including cancer, impacting
or translatable to the pediatric population. The unifying theme of research among center members is utilizing
systems biology approaches and sophisticated bioinformatics for studying disease mechanism. The goal of
Phase I was to establish the foundation of the center, expand the pool of successful investigators with a Faculty
Development Plan, and support systems-level core resources. Towards this goal, the center was created with a
nucleus of 4 Research Project Leaders and 2 research cores, Proteomics Core and Genomics & Bioinformatics
Core. Through use of a mentored Faculty Development Program overseen by the Administrative Core, the junior
investigators from Phase I received 9 RPG-level grants, including an U01-award. Additionally, we were able to
“graduate” both Phase I research cores to self-sustainability. Collectively, during the past 4 years of Phase I, we
have made substantial progress towards establishing a multi-disciplinary, thematic research center through
expansion of our center members, transitioning core resources to independence, and extramural funding –
demonstrating how the center is moving in the direction of long-term sustainability beyond COBRE support.
Building on the momentum of Phase I, our goals in Phase II are to further enhance our institutional research
infrastructure by developing our multi-disciplinary, thematic research center through strategic expansion of the
critical mass of investigators, investing into research infrastructure, and implementing a plan for long-term center
sustainability beyond COBRE support. We will provide structured mentoring and support to an initial group of 5
Research Project Leaders in Phase II. Furthermore, we will expand the pool of investigators in the center through
institutional commitments to recruit 4 Assistant and 1 Associate or Full Professor to the center. To support needs
of the expanding critical mass of investigators, we will develop a new Proteogenomics Core that is essential for
the evolving research mission of the center. This unique core will provide Research Project Leaders and other
center members access to experienced personnel for non-standard proteomic, genomic, and epigenomic
applications, and access to highly skilled bioinformaticians for cutting-edge data analysis and integration. To
support the expansion of investigators and a new research core, the Administrative Core will provide a Faculty
Development Plan, Pilot Project Program, operational oversight, and leadership as the center prepares to
transition to long-term sustainability. Upon completion of Phase II, we anticipate having a critical mass of junior,
mid-career, and senior investigators in the center who have access to world-class systems biology cores, which
will enable center members to successfully compete for individual, multi-investigator, and program-level grants
to support transition of the center to long-term sustainability beyond COBRE support.
摘要
2017年7月,我们在阿肯色州启动了科布雷转化性儿科研究中心第一阶段
阿肯色州小石城的儿童研究所。该中心的任务是利用蛋白质基因组学
确定影响包括癌症在内的疾病的表观基因组机制和治疗靶点的方法
或对儿科人群可翻译的。中心成员研究的统一主题是利用
研究疾病机制的系统生物学方法和尖端生物信息学。的目标是
第一阶段是建立中心的基础,扩大成功的调查员队伍
制定发展规划,支持系统级核心资源。为了实现这一目标,该中心是用一个
4个研究项目负责人和2个研究核心的核心,蛋白质组学核心和基因组和生物信息学
核心。通过使用由行政核心监督的指导教师发展计划,初级教师
第一阶段的研究人员获得了9项RPG级别的资助,其中包括一项U01奖。此外,我们还能够
“毕业”两个阶段的研究都是以自我维持为核心的。总体而言,在过去四年的第一阶段,我们
在建立一个多学科的专题研究中心方面取得了实质性进展,通过
我们中心成员的扩大,核心资源向独立的过渡,以及外部资金-
展示了该中心如何在科布雷支持之外朝着长期可持续发展的方向前进。
在第一阶段的基础上,我们在第二阶段的目标是进一步加强我们的院校研究
基础设施,通过战略扩张发展我们的多学科、主题研究中心
大量调查人员,投资于研究基础设施,并实施长期中心计划
超越科布雷支持的可持续性。我们将为最初的5人小组提供有组织的指导和支持
第二阶段的研究项目负责人。此外,我们将通过以下方式扩大中心的调查员队伍
机构承诺招聘4名助理和1名副教授或正教授到中心。支持需求
在不断扩大的研究人员临界量中,我们将开发一种新的蛋白质组学核心,这对于
该中心不断发展的研究任务。这一独特的核心将为研究项目负责人和其他人员提供
中心成员可以接触到经验丰富的人员,了解非标准蛋白质组、基因组和表观基因组
应用程序,以及获得高技能的生物信息学家,以进行尖端数据分析和集成。至
支持扩大调查人员和新的研究核心,行政核心将提供一个院系
发展计划、试点项目计划、运营监督和中心准备的领导力
向长期可持续性过渡。在第二阶段完成后,我们预计将有一个临界数量的初级,
职业生涯中期,以及该中心的高级研究员,他们可以接触到世界级的系统生物学核心,其中
将使中心成员能够成功地竞争个人、多名调查员和项目级别的拨款
支持中心向超越科布雷支持的长期可持续性过渡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alan Tackett其他文献
Alan Tackett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alan Tackett', 18)}}的其他基金
Identification of Druggable Targets to Complement Melanoma Therapy
确定可补充黑色素瘤治疗的药物靶点
- 批准号:
10163815 - 财政年份:2019
- 资助金额:
$ 77万 - 项目类别:
Identification of Druggable Targets to Complement Melanoma Therapy
确定可补充黑色素瘤治疗的药物靶点
- 批准号:
10630160 - 财政年份:2019
- 资助金额:
$ 77万 - 项目类别:
Identification of Druggable Targets to Complement Melanoma Therapy
确定可补充黑色素瘤治疗的药物靶点
- 批准号:
10412077 - 财政年份:2019
- 资助金额:
$ 77万 - 项目类别:
Center for Translational Pediatric Research (CTPR)
转化儿科研究中心 (CTPR)
- 批准号:
10380963 - 财政年份:2017
- 资助金额:
$ 77万 - 项目类别:
相似海外基金
Center: IUCRC Phase III University of Arkansas: Center for Membrane Applications, Science and Technology (MAST)
中心:IUCRC 第三阶段 阿肯色大学:膜应用、科学与技术中心 (MAST)
- 批准号:
2310905 - 财政年份:2024
- 资助金额:
$ 77万 - 项目类别:
Continuing Grant
Equipment: CC* Campus Compute: A High-Performance Computing System for Research and Education in Arkansas
设备:CC* 校园计算:用于阿肯色州研究和教育的高性能计算系统
- 批准号:
2346752 - 财政年份:2024
- 资助金额:
$ 77万 - 项目类别:
Standard Grant
Arkansas Department of Health's Rapid Response Team Building Project
阿肯色州卫生部的快速反应团队建设项目
- 批准号:
10830007 - 财政年份:2023
- 资助金额:
$ 77万 - 项目类别:
Building Capacity for Critical Need STEM and Special Education Teachers in Southeast Arkansas
阿肯色州东南部急需 STEM 和特殊教育教师的能力建设
- 批准号:
2243016 - 财政年份:2023
- 资助金额:
$ 77万 - 项目类别:
Standard Grant
Conference: Arkansas Spring Lecture Series
会议:阿肯色州春季系列讲座
- 批准号:
2247139 - 财政年份:2023
- 资助金额:
$ 77万 - 项目类别:
Standard Grant
REU Site: Summer Research in Physics at the University of Arkansas
REU 网站:阿肯色大学物理学暑期研究
- 批准号:
2244130 - 财政年份:2023
- 资助金额:
$ 77万 - 项目类别:
Standard Grant
Arkansas Department of Health's Wholesale/Manufactured Foods Maintenance for State Manufactured Food Programs and Special Project
阿肯色州卫生部针对州制造食品计划和特别项目的批发/制造食品维护
- 批准号:
10829501 - 财政年份:2023
- 资助金额:
$ 77万 - 项目类别:
Birth Defects Study to Evaluate Pregnancy exposureS (BD-STEPS) Core? Arkansas Center and Stillbirth
评估妊娠暴露的出生缺陷研究 (BD-STEPS) 核心?
- 批准号:
10765132 - 财政年份:2023
- 资助金额:
$ 77万 - 项目类别:
Cancer in Your Community: Strategies to Reduce Cancer and Chronic Disease in the Arkansas Delta
您所在社区的癌症:减少阿肯色三角洲癌症和慢性病的策略
- 批准号:
10780817 - 财政年份:2023
- 资助金额:
$ 77万 - 项目类别:
ExpandQISE: Track 2: QuAPB, Expanding Quantum Research and Education at the University of Arkansas at Pine Bluff
ExpandQISE:轨道 2:QuAPB,扩大阿肯色大学派恩布拉夫分校的量子研究和教育
- 批准号:
2228891 - 财政年份:2022
- 资助金额:
$ 77万 - 项目类别:
Standard Grant














{{item.name}}会员




